2025.01-至今：中国农业大学，教授

2020.05-2024.12：中国农业大学，副教授

2016.05-2020.04：北京食品营养与人类健康高精尖创新中心，岗位科学家

2014.12-2016.04：中国科学院生物物理研究所，副研究员

2012.07-2014.11：中国科学院生物物理研究所，助理研究员

2007.09-2012.06：中国科院生物物理研究所，细胞生物学，理学博士

2003.09-2007.06：四川大学，生命科学学院，生物科学，学士

奖励/教学：

1.中国农业大学杰出人才

2.校级优秀博士学位论文指导教师

3.获国际学术期刊等各类奖励20余次

4.指导学科竞赛获奖9次

5.指导学生获各类荣誉60余次

学术兼职：

1.国际期刊编委、青年编委、特刊主编

2.教育部学位论文评审专家

   营养与心血管健康

  1.国家自然科学基金面上项目，2025-2028，主持

  2.国家自然科学基金面上项目，2022-2025，主持

  3.国家自然科学基金面上项目，2020-2023，主持

  4.国家自然科学基金青年项目，2014-2016，主持

  5.国家重点研发计划子课题，2024-2028，主持

  6.国家重点研发计划子课题，2022-2026，主持

  7.北京市自然科学基金面上项目，2026-2028，主持

  8.北京市自然科学基金面上项目，2022-2024，主持

长期致力于营养与心血管健康的基础与转化工作，阐明了心衰、心梗、动脉粥样硬化、主动脉夹层等重大心血管疾病的发病机制，揭示了膳食营养素对心血管的保护作用，为心血管疾病的防治提供了新方案。共发表论文90余篇，代表性论文：

1. Yongting Luo*, Junjie Luo*, Peng An*, Yuanfei Zhao*, Wenting Zhao*, Zhou Fang, Yi Xia, Lin Zhu, Teng Xu, Xu Zhang, Shuaishuai Zhou, Mingyan Yang, Jiayao Li, Junming Zhu, Yongmin Liu, Haiyang Li, Ming Gong, Yuyong Liu, Jie Han, Huiyuan Guo#, Hongjia Zhang#, Wenjian Jiang#, Fazheng Ren#. The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture. Eur Heart J. 2024 Jan 27;45(4):287-305.

-Editorial Comment: Miteva K. On target inhibition of vascular smooth muscle cell phenotypic transition underpins TNF-OXPHOS-AP-1 as a promising avenue for anti-remodelling interventions in aortic dissection and rupture. Eur Heart J. 2023 Nov 24:ehad679. doi: 10.1093/eurheartj/ehad679 (同期专评)

-ISSUE @ A GLANCE: Crea F. Focus on vascular biology: new therapeutic targets in atherosclerosis, aortic dissection, and peripheral artery disease. Eur Heart J. 2024 Jan 27;45(4):239-242. doi: 10.1093/eurheartj/ehae004 (主编推荐)

2. Wenting Zhao, Peina Wang, Zhengxun Liu, Dongyuan Zhang, Yi Xia, Teng Xu, Fei Wang, Xu Zhang, Shuaishuai Zhou, Zhixi Wei, Min Ma, Sitong Wan, Jingyi Qi, Zhengyang Zhang, Juan Chen, Libing Liu, Yinhua Zhu, Junjie Luo#, Yongting Luo#, Peng An#. The endothelial mTORC2-Foxo1 axis serves as an iron-responsive sensor governing systemic iron homeostasis. Blood. 2025 Jun 25:blood.2025028454. (封面文章，同期专评)

3. Teng Xu*, Xu Zhang*, Wenting Zhao, Sitong Wan, Jingjing He, Li Jiang, Hao Wang, Yanling Hao, Hong Gao#, Junjie Luo#, Yongting Luo#, Peng An#. Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis. Blood. 2024 Sep 19;144(12):1314-1328. (封面文章，同期专评)

4. Jianan Chen*, Yongting Luo*, Hui Hui, Tanxi Cai, Hongxin Huang, Fuquan Yang, Jing Feng, Jingjing Zhang#, Xiyun Yan#. CD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development. Proc Natl Acad Sci U S A. 2017;114(36):E7622-E7631. (Faculty1000推荐“新发现、新药靶点”)

5. Yongting Luo#, Xiao Teng, Lingling Zhang, Jianan Chen, Zheng Liu, Xuehui Chen, Shuai Zhao, Sai Yang, Jing Feng, Xiyun Yan#. CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nature Communications. 2019 Aug 7;10(1):3551.

6. Luo Y*, Duan H*, Qian Y*, Feng L, Wu Z, Wang F, Feng J, Yang D, Qin Z, Yan X#. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. Cell Research. 2017;27(3):352-372. (封面文章)

7. Wenting Zhao*, Juan Chen*, Yi Xia*, Sitong Wan, Yanling Hao, Fazheng Ren#, Peng An#, Yongting Luo#, Junjie Luo#. Temporal-specific single cell atlas of human type A aortic dissection reveals immune cell dynamics and therapeutic targets. Science Bulletin. 2025 Jan 30;70(2):167-171.

8. Zhu Y*, Zhang Y*, Zhang Q*, Song P*, Zhang J, Ma A, Wang C, Gao P, Yang T, Zhou L, Shi Q, Wong YK, Luo Y#, Tang H#, Wang J#. Caffeic Acid Acts as a Potent Senomorphic and Alleviates Inflammation and Lung Fibrosis by Covalently Targeting Annexin A5 Protein in Mice. Exploration. 2025 Dec 12;5(6):20240069.

9. Zhengyang Zhang*, Xingwang Zhao*, Xu Zhang, Sitong Wan, Peng An, Yinhua Zhu, Yongting Luo#, Junjie Luo#. Mitochondrial Cardiovascular Diseases: Molecular Mechanisms, Multi-omics Exploration and Therapeutic Strategies. Journal of Advanced Research. 2025 Jul 16:S2090-1232(25)00546-6.

10. Lingling Zhang*, Yongting Luo*, Xiao Teng, Zhenzhen Wu, Mengtao Li, Dong Xu, Qian Wang, Fei Wang, Jing Feng#, Xiaofeng Zeng#, Xiyun Yan#. CD146: a potential therapeutic target for systemic sclerosis. Protein & Cell, 2018;9(12):1050-1054

11. Jianan Chen*, Yongting Luo*, Hongxin Huang, Shuilong Wu, Jing Feng, Jingjing Zhang, Xiyun Yan. CD146 is essential for PDGFRβ-induced pericyte recruitment. Protein & Cell, 2018;9(8):743-747.

12. Wan S, Qi J, Xia Y, Fan C, Xu T, Zhang X, Shi J, Wang C, Cheng Y, Zhang D, Liu R, Zhu Y, Cao C, Jin D, An P#, Luo Y#, Luo J#. Cardiac Slc25a49-Mediated Energy Reprogramming Governs Doxorubicin-Induced Cardiomyopathy through the G6P-AP-1-Sln Axis. Adv Sci (Weinh). 2025 Jul;12(26):e2502163.

13. Xuan Wang*, Yuting Ji*, Jingyi Qi, Shuaishuai Zhou, Sitong Wan, Chang Fan, Peng An#, Yongting Luo#, Junjie Luo#. Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells. Cell Death & Disease. 2023 Aug 8;14(8):508

14. Wenyi Xu, Huijuan Hua, Yueh-Ho Chiu, Guannan Li, Huihan Zhi, Zhengquan Yu, Fazheng Ren, Yongting Luo#, Wei Cui#. CD146 regulates growth factor-induced mTORC2 activity independent of PI3K and mTORC1 pathways. Cell Reports. 2019;29(5):1311-1322

15. Zhang X*, An P*, Zhang Z, Hao Y, Guo X, Zhu Y, Gu Z#, Luo Y#, Luo J#. Single-cell Omics Assessment of Mitochondrial Function: Current Status and Future Perspectives. Genomics Proteomics Bioinformatics. 2025 Sep 17:qzaf081.

16. Xi X*, Hu S*, Zhang X, An P#, Luo Y#, Luo J#, Zhu Y#. Bioactives in Food-As-Medicine for Special Medical Purposes. Adv Nutr. 2025 Dec;16(12):100546.

17. Xu T, Zhang X, Liu Y, Wang H, Luo J#, Luo Y#, An P#. Effects of dietary polyphenol supplementation on iron status and erythropoiesis: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021 Apr 19:nqab068

18. Shuaishuai Zhou, Fangxiao Cheng, Jian He, Teng Xu, Xu Zhang, Sitong Wan, Jingyi Qi, Jingjing He, Fangyan Chen, Junjie Luo#, Yongting Luo#, Peng An#. Effects of high-quality protein supplementation on cardiovascular risk factors in individuals with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition. 2024 Jun 15;43(8):1740-1750

19. Fan C, Wu J, Hu S, Xia Y, Wei Z, Tang H, Jin W, Zhang Z, An P, Luo J#, Luo Y#, Zhu Y#. Rosmarinic acid alleviates doxorubicin-induced cellular senescence and cardiotoxicity by targeting the 14-3-3/Foxo1 signaling axis. Phytomedicine. 2025 Nov 25;148:157482.

20. Wu Y*, Zhang X*, Zhang Z, An P, He Y, Zhang H#, Luo Y#, Luo J#. Mitochondrial DNA mutations as a potential modifier for the clinical variability of marfan syndrome. QJM. 2025 Sep 18:hcaf188.

教材/著作：

1. 《人体病理学》，中国轻工业出版社，2026，主编

2. Metabolic Features and Nutritional Interventions in Chronic Diseases, Nutrients, 2025, 主编

3. The Effects of dietary protein and polysaccharide fortification on disease, Nutrients, 2023, 主编

4. Micronutrients and metabolic diseases. Frontiers in Nutrition, 2024, 主编

5. Micronutrients and metabolic diseases-II. Frontiers in Nutrition, 2026, 主编